UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation and management of ALS

Journal of the neurological sciences, 2015-10, Vol.357, p.e489-e490

Kiernan, M.C

2015

Volltextzugriff (PDF)

Demyelinating neuropathies

Journal of the neurological sciences, 2015-10, Vol.357, p.e511-e511

Kiernan, M.C

2015

Volltextzugriff (PDF)

Riluzole, neuroprotection and amyotrophic lateral sclerosis

Current medicinal chemistry, 2010-06, Vol.17 (18), p.1942-1959

2010

Volltextzugriff (PDF)

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies

Journal of neuroimmunology, 2017-08, Vol.309, p.41-46

2017

Volltextzugriff (PDF)

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy

Journal of the neurological sciences, 2021-04, Vol.423, p.117358-117358, Article 117358

2021

Volltextzugriff (PDF)

S3-4 Toxic and metabolic neuropathy

Clinical neurophysiology, 2010, Vol.121, p.S14-S14

Kiernan, M.C

2010

Volltextzugriff (PDF)

S44-1 Physiological studies in channel disorders

Clinical neurophysiology, 2010, Vol.121, p.S63-S63

Kiernan, M.C

2010

Volltextzugriff (PDF)

Association Between Calcineurin Inhibitor Treatment and Peripheral Nerve Dysfunction in Renal Transplant Recipients

American journal of transplantation, 2013-09, Vol.13 (9), p.2426-2432

2013

Volltextzugriff (PDF)

Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy

Clinical neurophysiology, 2017-01, Vol.128 (1), p.227-232

2017

Volltextzugriff (PDF)

8. Exploring motor imagery and motor cortical function in amyotrophic lateral sclerosis using magnetoencephalography

Clinical neurophysiology, 2016-03, Vol.127 (3), p.e12-e12

2016

Volltextzugriff (PDF)

Saccadic abnormalities in frontotemporal dementia

Neurology, 2012-06, Vol.78 (23), p.1816-1823

2012

Volltextzugriff (PDF)

Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis

Current medicinal chemistry, 2015-01, Vol.22 (38), p.4366-4378

2015

Volltextzugriff (PDF)

7. Effects of fampridine PR on axonal function in multiple sclerosis

Clinical neurophysiology, 2014-04, Vol.125 (4), p.e3-e3

2014

Volltextzugriff (PDF)

12. All axons are not equal

Clinical neurophysiology, 2012-07, Vol.123 (7), p.e72-e73

2012

Volltextzugriff (PDF)

P222: Sensory axonal dysfunction in asymptomatic diabetic patients

Clinical neurophysiology, 2014-06, Vol.125, p.S107-S107

2014

Volltextzugriff (PDF)

6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy

Clinical neurophysiology, 2014-04, Vol.125 (4), p.e3-e3

2014

Volltextzugriff (PDF)

3041 POSTER Oxaliplatin-induced Neurotoxicity – Comparing Four Methods of Assessment

European journal of cancer (1990), 2011, Vol.47, p.S234-S234

2011

Volltextzugriff (PDF)

W1.4 In vivo evidence of neurophysiological differentiation between type 1 and type 2 diabetic nerves

Clinical neurophysiology, 2011, Vol.122, p.S7-S7

2011

Volltextzugriff (PDF)

P7-14 Clinical and neurophysiological characteristics of an isolated bulbar phenotype of ALS

Clinical neurophysiology, 2010, Vol.121, p.S143-S144

2010

Volltextzugriff (PDF)

61. Cortical excitability testing in Kennedy’s disease

Clinical neurophysiology, 2008-03, Vol.119 (3), p.e45-e46

2008

Volltextzugriff (PDF)

6147 POSTER A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity

European journal of cancer (1990), 2011, Vol.47, p.S436-S436

2011

Volltextzugriff (PDF)

P21-5 Sural nerve excitability: Implications for the early identification of peripheral nerve dysfunction

Clinical neurophysiology, 2010, Vol.121, p.S227-S227

2010

Volltextzugriff (PDF)

5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity

Clinical neurophysiology, 2010-04, Vol.121 (4), p.e2-e2

2010

Volltextzugriff (PDF)

P4.17 Novel neurophysiological insights into uraemic neuropathy: implications for clinical trials

Clinical neurophysiology, 2011, Vol.122, p.S75-S75

2011

Volltextzugriff (PDF)

S27-7 Porphyric neuropathy: insane in the membrane

Clinical neurophysiology, 2010, Vol.121, p.S43-S43

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)
Buchkapitel
(1)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation and management of ALS

Demyelinating neuropathies

Riluzole, neuroprotection and amyotrophic lateral sclerosis

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy

S3-4 Toxic and metabolic neuropathy

S44-1 Physiological studies in channel disorders

Association Between Calcineurin Inhibitor Treatment and Peripheral Nerve Dysfunction in Renal Transplant Recipients

Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy

8. Exploring motor imagery and motor cortical function in amyotrophic lateral sclerosis using magnetoencephalography

Saccadic abnormalities in frontotemporal dementia

Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis

7. Effects of fampridine PR on axonal function in multiple sclerosis

12. All axons are not equal

P222: Sensory axonal dysfunction in asymptomatic diabetic patients

6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy

3041 POSTER Oxaliplatin-induced Neurotoxicity – Comparing Four Methods of Assessment

W1.4 In vivo evidence of neurophysiological differentiation between type 1 and type 2 diabetic nerves

P7-14 Clinical and neurophysiological characteristics of an isolated bulbar phenotype of ALS

61. Cortical excitability testing in Kennedy’s disease

6147 POSTER A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity

P21-5 Sural nerve excitability: Implications for the early identification of peripheral nerve dysfunction

5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity

P4.17 Novel neurophysiological insights into uraemic neuropathy: implications for clinical trials

S27-7 Porphyric neuropathy: insane in the membrane

Suchergebnisse filtern